San Francisco, CA – The Division of Workers’ Compensation (DWC) has posted an interim status report on its efforts to promulgate regulations for an evidence-based workers’ compensation drug formulary as required by Assembly Bill 1124.
The drug formulary must be adopted by July 1, 2017, and must be consistent with California’s Medical Treatment UtilizationSchedule (MTUS), for medications prescribed in the workers’ compensation system.
Assembly Bill 1124 (Statutes 2015, Chapter 525) requires DWC adopt the evidence based workers’ compensation drug formulary in consultation with the Commission on Health and Safety and Workers’ Compensation, and that DWC’s administrative director meet and consult with stakeholders. The legislation further requires posting of a minimum of two interim reports describing the status of the formulary’s creation.
The status report is available here:
CA DWC: AB 1124: Drug Formulary in the California Workers’ Compensation System Interim Status Report (PDF)
Source: CA DWC